Effect of Nutritional Support in Patients with Lower Respiratory Tract Infection: Secondary Analysis of a Randomized Clinical Trial
Authors
Affiliations
Background: In polymorbid patients with bronchopulmonary infection, malnutrition is an independent risk factor for mortality. There is a lack of interventional data investigating whether providing nutritional support during the hospital stay in patients at risk for malnutrition presenting with lower respiratory tract infection lowers mortality.
Methods: For this secondary analysis of a randomized clinical trial (EFFORT), we analyzed data of a subgroup of patients with confirmed lower respiratory tract infection from an initial cohort of 2028 patients. Patients at nutritional risk (Nutritional Risk Screening [NRS] score ≥3 points) were randomized to receive protocol-guided individualized nutritional support to reach protein and energy goals (intervention group) or standard hospital food (control group). The primary endpoint of this analysis was all-cause 30-day mortality.
Results: We included 378 of 2028 EFFORT patients (mean age 74.4 years, 24% with COPD) into this analysis. Compared to usual care hospital nutrition, individualized nutritional support to reach caloric and protein goals showed a similar beneficial effect of on the risk of mortality in the subgroup of respiratory tract infection patients as compared to the main EFFORT trial (odds ratio 0.47 [95%CI 0.17 to 1.27, p = 0.136] vs 0.65 [95%CI 0.47 to 0.91, p = 0.011]) with no evidence of a subgroup effect (p for interaction 0.859). Effects were also similar among different subgroups based on etiology and type of respiratory tract infection and for other secondary endpoints.
Conclusion: This subgroup analysis from a large nutrition support trial suggests that patients at nutritional risk as assessed by NRS 2002 presenting with bronchopulmonary infection to the hospital likely have a mortality benefit from individualized inhospital nutritional support. The small sample size and limited statistical power calls for larger nutritional studies focusing on this highly vulnerable patient population.
Clinical Trial Registration: Registered under ClinicalTrials.gov Identifier no. NCT02517476.
Justel Enriquez A, Rabat-Restrepo J, Vilchez-Lopez F, Tenorio-Jimenez C, Garcia-Almeida J, Irles Rocamora J Nutrients. 2024; 16(18).
PMID: 39339705 PMC: 11434837. DOI: 10.3390/nu16183105.
Keller B, Wunderle C, Tribolet P, Stanga Z, Kaegi-Braun N, Mueller B BMJ Open. 2024; 14(8):e084754.
PMID: 39153787 PMC: 11535698. DOI: 10.1136/bmjopen-2024-084754.
Fekete M, Csipo T, Fazekas-Pongor V, Balint M, Csizmadia Z, Tarantini S Nutrients. 2023; 15(18).
PMID: 37764686 PMC: 10536642. DOI: 10.3390/nu15183902.
Inflammation and Nutrition: Friend or Foe?.
Stumpf F, Keller B, Gressies C, Schuetz P Nutrients. 2023; 15(5).
PMID: 36904164 PMC: 10005147. DOI: 10.3390/nu15051159.
Subclinical Kwashiorkor in Adults: A New Age Paradigm.
Kapoor N, Bhattacharya S, Agarwal N, Das S, Bantwal G, Deshmukh V Indian J Endocrinol Metab. 2022; 26(3):213-222.
PMID: 36248046 PMC: 9555378. DOI: 10.4103/ijem.ijem_42_22.